Biography
Dr. Arturo Loaiza-Bonilla, MD, MSEd, FACP is a physician–scientist and oncology executive operating at the intersection of clinical medicine, artificial intelligence, and large-scale clinical research infrastructure.
Clinical interests / subspecialty
Biomarker-driven cancers; immunotherapy; complex trial-based care; clinical trial access/matching infrastructure; neurosymbolic & multi-agent AI platforms
Education & training
Medical School: University of Miami Miller School of Medicine
Residency: St. Luke's-Roosevelt Hospital Center, Columbia University, Internal Medicine
Fellowship: Post-Doctorate Fellow, Hematology and Oncology (University of Miami Miller School of Medicine)
Other training: Master of Medical Education (MSEd), Medical Education (University of Pennsylvania)
Board certifications / licenses
- ABIM - Medical Oncology
- ABIM - Internal Medicine
Professional memberships
ASCO, AACR, ACP (Fellow)
Languages
English (native); French (professional working proficiency); Japanese (elementary proficiency); Spanish (native or bilingual proficiency)
Research areas
AI in clinical trials; neurosymbolic / multi-agent AI architectures; digital health; real-world data activation; precision oncology systems
Clinical research experience
Phase I–III clinical trial leadership and portfolios across oncology networks
Leadership & recognition
- 40 under 40 in Cancer; Philadelphia Business Journal “40 Under 40”; Castle Connolly / Philadelphia Magazine Top Doctors (since 2018)
Publications & media
- 80+ peer-reviewed publications in NEJM AI, JCO, Lancet Oncology, ESMO and JAMA Oncology
- PubMed
Arturo Loaiza-Bonilla reviews Massive Bio content as part of our Medical Review Board, ensuring medical accuracy and clinical currency across our cancer resources.
Content reviewed by Arturo Loaiza-Bonilla
Lymphoma
NOVEMBER 2025
Ewing Sarcoma Signs & Symptoms
NOVEMBER 2025
Causes and Risk Factors for Endometrial Cancer
NOVEMBER 2025
Survival Rate and Prognosis for Endometrial Cancer
NOVEMBER 2025
Survival Rate and Prognosis for Cholangiocarcinoma
NOVEMBER 2025
Diagnosis, Screening, and Early Detection of Anal Cancer
NOVEMBER 2025
Diagnosis, Screening, and Early Detection of Squamous Cell Carcinoma
NOVEMBER 2025
Non-Hodgkin Lymphoma Treatment Options
NOVEMBER 2025
Survival Rate and Prognosis for Chronic Lymphocytic Leukemia
NOVEMBER 2025
Acute Lymphoblastic Leukemia Treatment Options
OCTOBER 2025
Survival Rate and Prognosis for Leukemia
OCTOBER 2025
Prevention Tips for Leukemia
OCTOBER 2025
Acute Lymphoblastic Leukemia
OCTOBER 2025